GLP-1 coverage in Michigan
Medicaid does cover GLP-1s for obesity here. What that means, the indications that are still mandatory, and what it costs if you pay cash.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
Michigan Medicaid covers GLP-1s for obesity — but has narrowed who qualifies.
Michigan is one of the states KFF lists as covering GLP-1s for obesity treatment. It has also restricted eligibility to patients with morbid obesity rather than those who are overweight or obese, a change expected to save the state an estimated $240 million. Everything below is sourced — we are not going to tell you what a Michigan clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.
Why Michigan is different
Michigan is the clearest example in the country of the middle path states are taking: not eliminating coverage outright, but tightening the threshold until the budget works. That is a materially different situation from California or Pennsylvania, where the route closed entirely — and it means the question here is not whether coverage exists but whether you clear the bar.
Medicaid and GLP-1s in Michigan
Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Michigan sits.
| Michigan | |
|---|---|
| Status | Medicaid does cover GLP-1s for obesity here |
| Region | Midwest — regional adult obesity prevalence 35.9% |
| Board of pharmacy | Michigan Board of Pharmacy |
If you are on Medicaid in Michigan
What to do in Michigan: Find out the specific BMI threshold and documentation your plan requires before you apply, because in Michigan eligibility is where applications now fail rather than at the coverage question.
Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.
Paying cash in Michigan
Providers are licensed across all 50 states and charge the same here as anywhere, so there is no local price to hunt for — the cheapest verified all-in rates are Ozari Health at $86 for semaglutide and Trimi at $125 for tirzepatide. Full tables in the cheapest tirzepatide. If you buy compounded, check the pharmacy licence with the Michigan Board of Pharmacy, or with the board in whichever state that pharmacy actually operates from — frequently not Michigan.
Michigan: common questions
Does Michigan still cover Wegovy or Zepbound?
KFF lists Michigan among the states covering GLP-1s for obesity. The restriction is on who qualifies — the state narrowed eligibility to morbid obesity rather than overweight or obese — not on whether the drugs are covered at all.
What does the $240 million figure refer to?
It is the saving Michigan expects from restricting eligibility to morbidly obese patients. It is a useful number to hold onto because it shows what is driving these decisions nationally: budget, not clinical evidence.
Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.
Read next
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
- Trimi tirzepatide review
Lowest flat price with named pharmacies. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $125 a month.